The increase in circulating levels of DPP-4 occurring during obesity could determine a pronounced inactivation of endogenous GLP-1, thus reducing the insulinotropic action of GLP-1 and consequently insulin secretion. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.